• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc ALNY

Last Price$54.31Day Change (%)-4.64%
Open Price$54.00Day Change ($)-2.64
Day Range53.00–55.5452-Week Range49.96–137.89

As of Fri 6/24/2016 5:00:00 PM | USD

  1. All
  2. 3rd Party
  1. Hyperoxaluria Therapeutics Pipeline Report 2016 - Review of Allena Pharma, Alnylam Pharma , Dicerna Pharma, Digna Biotech & OxThera - Research and Markets

    Hyperoxaluria Therapeutics Pipeline Report 2016 - Review of Allena Pharma, Alnylam Pharma , Dicerna Pharma, Digna Biotech & OxThera - Research and Markets

  2. Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

    Global Hypercholesterolemia Pipeline Report 2016 - Therapeutics Review of 36 Companies & Drug Profile Activity - Research and Markets

  3. Global Hemophilia A Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: Baxalta, Bayer, Biogen - Research and Markets

    Global Hemophilia A Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: Baxalta, Bayer, Biogen - Research and Markets

  4. Kinesin Spindle Protein (KSP or Eg5) - Pipeline Review, H1 2016 - Research and Markets

    Kinesin Spindle Protein (KSP or Eg5) - Pipeline Review, H1 2016 - Research and Markets

  5. Global Bladder Cancer Pipeline Report 2016 - Review of 94 Companies & Drug Profiles - Research and Markets

    Global Bladder Cancer Pipeline Report 2016 - Review of 94 Companies & Drug Profiles - Research and Markets

  6. Ionis's Shares Fall After Co-Developer Opts Against a Late-Stage Trial -- 2nd Update

    Ionis's Shares Fall After Co-Developer Opts Against a Late-Stage Trial -- 2nd Update

  7. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.